Today's Daily Dose brings you news about the expanding footprint of Apyx Medical's Helium Plasma Technology products; Inovio securing a $71 million funding from the U.S. Department of Defense for its COVID-19 vaccine delivery systems and Myovant's positive results from its second phase III trial of Relugolix combination therapy in women with pain associated with endometriosis, among others.
from RTT - Biotech https://ift.tt/2Z2noS6
via IFTTT
No comments:
Post a Comment